Phytogenic silver, gold, and bimetallic nanoparticles as novel antitubercular agents

Autor: Manisha Arkile, Laxman Nawale, Utkarsha U. Shedbalkar, Snehal Chopade, Dhiman Sarkar, Sweety A. Wadhwani, Balu A. Chopade, Richa Singh
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Plumbago zeylanica
Materials science
Silver
medicine.drug_class
mycobacteria
030106 microbiology
Biophysics
Antitubercular Agents
Drug Evaluation
Preclinical

Pharmaceutical Science
Metal Nanoparticles
Bioengineering
02 engineering and technology
Microbial Sensitivity Tests
Pharmacology
Antimycobacterial
Cell Line
Biomaterials
Mycobacterium tuberculosis
03 medical and health sciences
Minimum inhibitory concentration
Plumbaginaceae
International Journal of Nanomedicine
Acanthaceae
Drug Discovery
medicine
antimycobacterial agent
Humans
Cytotoxicity
Original Research
drug resistance
Plants
Medicinal

biology
Macrophages
Organic Chemistry
General Medicine
021001 nanoscience & nanotechnology
biology.organism_classification
Mycobacterium bovis
In vitro
tuberculosis
cytotoxicity
nanoparticles
Gold
0210 nano-technology
Ex vivo
Barleria prionitis
Zdroj: International Journal of Nanomedicine
ISSN: 1178-2013
1176-9114
Popis: Richa Singh,1 Laxman Nawale,2 Manisha Arkile,2 Sweety Wadhwani,1 Utkarsha Shedbalkar,1 Snehal Chopade,1 Dhiman Sarkar,2 Balu Ananda Chopade1,3 1Department of Microbiology, Savitribai Phule Pune University, 2Combichem-Bioresource Center, Organic Chemistry Division, National Chemical Laboratory, Pune, 3Dr Babasaheb Ambedkar Marathwada University, Aurangabad, Maharashtra, India Purpose: Multi- and extensively drug-resistant tuberculosis (TB) is a global threat to human health. It requires immediate action to seek new antitubercular compounds and devise alternate strategies. Nanomaterials, in the present scenario, have opened new avenues in medicine, diagnosis, and therapeutics. In view of this, the current study aims to determine the efficacy of phytogenic metal nanoparticles to inhibit mycobacteria. Methods: Silver (AgNPs), gold (AuNPs), and gold–silver bimetallic (Au–AgNPs) nanoparticles synthesized from medicinal plants, such as Barleria prionitis, Plumbago zeylanica, and Syzygium cumini, were tested against Mycobacterium tuberculosis and M. bovis BCG. In vitro and ex vivo macrophage infection model assays were designed to determine minimum inhibitory concentration (MIC) and half maximal inhibitory concentration of nanoparticles. Microscopic analyses were carried out to demonstrate intracellular uptake of nanoparticles in macrophages. Besides this, biocompatibility, specificity, and selectivity of nanoparticles were also established with respect to human cell lines. Results: Au–AgNPs exhibited highest antitubercular activity, with MIC of
Databáze: OpenAIRE